-
Something wrong with this record ?
The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters
P Richtrova, K Jr Opatrny, L Vit, F Sefrna, R Perlik
Language English Country Great Britain
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
- MeSH
- Adsorption MeSH
- Acrylic Resins chemistry MeSH
- Biocompatible Materials MeSH
- Time Factors MeSH
- Equipment Design MeSH
- Renal Dialysis methods instrumentation MeSH
- Financing, Organized MeSH
- Hemodialysis Solutions chemistry MeSH
- Heparin chemistry MeSH
- Cross-Over Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Prospective Studies MeSH
- Randomized Controlled Trials as Topic MeSH
- Reproducibility of Results MeSH
- Aged MeSH
- Sensitivity and Specificity MeSH
- Platelet Factor 4 chemistry MeSH
- Blood Platelets metabolism MeSH
- Thrombosis MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
BACKGROUND: Thrombogenicity is an important parameter of haemodialysis (HD) membrane biocompatibility. The surface of the polyacrylonitrile AN69 ST membrane is coated with a polyethylenimine. This modification allows heparin adsorption. The binding of heparin to the membrane surface occurs during priming of the extracorporeal circuit (ECC) by rinsing it with saline and heparin. Our aims were to assess and compare the thrombogenicity of the AN69 ST membrane under conditions of two extracorporeal circuit (ECC) rinse protocols-with and without unfractionated heparin (UFH). METHODS: In a prospective, crossover and randomized study, we examined 10 patients during HD after ECC preparation with either rinse protocols. Prior to HD and at 15, 60 and 240 min, we determined plasma levels of the thrombin-antithrombin complexes (TAT), platelet factor 4 (PF4), heparin concentration (antiXa) and thrombocyte count. Systemic anticoagulation was performed using UFH. RESULTS: During HD after ECC rinse without UFH, there was a significantly earlier and more marked increase in TAT compared with UFH-containing rinse (P <0.05). Using Spearman coefficient, we demonstrated a significant correlation between TAT and antiXa at 60 min (r = -0.534) and 240 min (r = -0.538). A comparison of the TAT/antiXa ratios between rinses at 60 min revealed a significantly higher increase in TAT following UFH-free rinse (P <0.05). There was no difference in PF4 between the rinses. Platelet count did not change significantly during HD using either rinse protocol. CONCLUSION: Based on plasma TAT levels, ECC priming with an UFH-containing solution reduces the thrombogenicity of the AN69 ST membrane. There is no significant difference between both types of priming concerning PF4 and thrombocyte count.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026372
- 003
- CZ-PrNML
- 005
- 20111210192331.0
- 008
- 101018s2007 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Richtrová, Pavlína, $d 1975- $7 xx0074467
- 245 14
- $a The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters / $c P Richtrova, K Jr Opatrny, L Vit, F Sefrna, R Perlik
- 314 __
- $a Department of Internal Medicine I, Charles University, Medical School and Teaching Hospital, Alej Svobody 80, 30460 Plzen, Czech Republic. richtrovap@fnplzen.cz
- 520 9_
- $a BACKGROUND: Thrombogenicity is an important parameter of haemodialysis (HD) membrane biocompatibility. The surface of the polyacrylonitrile AN69 ST membrane is coated with a polyethylenimine. This modification allows heparin adsorption. The binding of heparin to the membrane surface occurs during priming of the extracorporeal circuit (ECC) by rinsing it with saline and heparin. Our aims were to assess and compare the thrombogenicity of the AN69 ST membrane under conditions of two extracorporeal circuit (ECC) rinse protocols-with and without unfractionated heparin (UFH). METHODS: In a prospective, crossover and randomized study, we examined 10 patients during HD after ECC preparation with either rinse protocols. Prior to HD and at 15, 60 and 240 min, we determined plasma levels of the thrombin-antithrombin complexes (TAT), platelet factor 4 (PF4), heparin concentration (antiXa) and thrombocyte count. Systemic anticoagulation was performed using UFH. RESULTS: During HD after ECC rinse without UFH, there was a significantly earlier and more marked increase in TAT compared with UFH-containing rinse (P <0.05). Using Spearman coefficient, we demonstrated a significant correlation between TAT and antiXa at 60 min (r = -0.534) and 240 min (r = -0.538). A comparison of the TAT/antiXa ratios between rinses at 60 min revealed a significantly higher increase in TAT following UFH-free rinse (P <0.05). There was no difference in PF4 between the rinses. Platelet count did not change significantly during HD using either rinse protocol. CONCLUSION: Based on plasma TAT levels, ECC priming with an UFH-containing solution reduces the thrombogenicity of the AN69 ST membrane. There is no significant difference between both types of priming concerning PF4 and thrombocyte count.
- 650 _2
- $a akrylové pryskyřice $x chemie $7 D000180
- 650 _2
- $a adsorpce $7 D000327
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biokompatibilní materiály $7 D001672
- 650 _2
- $a trombocyty $x metabolismus $7 D001792
- 650 _2
- $a klinické křížové studie $7 D018592
- 650 _2
- $a design vybavení $7 D004867
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hemodialyzační roztoky $x chemie $7 D015312
- 650 _2
- $a heparin $x chemie $7 D006493
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a trombocytový faktor 4 $x chemie $7 D010978
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a dialýza ledvin $x metody $x přístrojové vybavení $7 D006435
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a trombóza $7 D013927
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 700 1_
- $a Opatrný, Karel, $d 1954-2006 $7 nlk19990073633
- 700 1_
- $a Vít, Ladislav, $d 1962- $7 xx0138815
- 700 1_
- $a Šefrna, František. $7 xx0179993
- 700 1_
- $a Perlík, Radek $7 xx0142913
- 773 0_
- $w MED00010288 $t Nephrology, dialysis, transplantation $g Roč. 22, č. 10 (2007), s. 2978-2984 $x 0931-0509
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110112131936 $b ABA008
- 991 __
- $a 20110117105730 $b ABA008
- 999 __
- $a ok $b bmc $g 801477 $s 666224
- BAS __
- $a 3
- BMC __
- $a 2007 $b 22 $c 10 $d 2978-2984 $i 0931-0509 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
- LZP __
- $a 2010-B/mk